G. Perera

Inhibitor treatment of peripheral mononuclear cells from Parkinson’s disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarker

G. Perera, Madelaine Ranola, Dominic B. Rowe et al. · Scientific Reports · 2016 · 261 citations · Full text

Actions of the protein kinase WNK1 on endothelial cells are differentially mediated by its substrate kinases OSR1 and SPAK

Hashem A. Dbouk, Lauren M. Weil, G. Perera et al. · Proceedings of the National Academy of Sciences · 2014 · 71 citations · Full text

Endothelial Cells, Cellular Physiology, Blood Pressure +18

Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients

G. Perera, Fiona Child, Nigel Heaton et al. · British Journal of Dermatology · 2006 · 62 citations

Bullous subacute cutaneous lupus erythematosus

G. Perera, Martin M. Black, D. McGibbon · Clinical and Experimental Dermatology · 2004 · 29 citations

Rheumatology, Initial Rash, Systemic Lupus Erythematosus +10

Mitochondrial Dysfunction Precedes Other Sub-Cellular Abnormalities in an In Vitro Model Linked with Cell Death in Parkinson’s Disease

C. J. Yong-Kee, Elena S Sidorova, Asad Hanif et al. · Neurotoxicity Research · 2011 · 27 citations

Neurodegenerative Diseases, Mitochondrial Function, Vitro Model Linked +11